Delek US Holdings, Inc. (NYSE:DK - Get Free Report) has received a consensus rating of "Moderate Buy" from the fourteen research firms that are presently covering the stock, Marketbeat Ratings reports. Seven analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $77.75.
Several research analysts recently commented on DK shares. Morgan Stanley boosted their target price on Delek US from $45.00 to $81.00 and gave the stock an "equal weight" rating in a research note on Monday, September 14th. Weiss Ratings upgraded Delek US from a "hold (c+)" rating to a "buy (b-)" rating in a report on Thursday, October 8th. Freedom Broker raised Delek US from a "hold" rating to a "buy" rating and increased their price target for the company from $86.00 to $88.00 in a research report on Wednesday. Wells Fargo & Company lifted their price objective on Delek US from $82.00 to $95.00 and gave the company an "overweight" rating in a research note on Wednesday, October 14th. Finally, TD Cowen lifted their price objective on Delek US from $85.00 to $90.00 and gave the company a "buy" rating in a research note on Thursday, October 22nd.
Check Out Our Latest Report on DK
Insider Transactions at Delek US
In related news, Director Vicky Sutil sold 6,397 shares of Delek US stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $71.50, for a total value of $457,385.50. Following the completion of the transaction, the director owned 26,407 shares in the company, valued at $1,888,100.50. The trade was a 19.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Reuven Spiegel sold 7,500 shares of the business's stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $73.21, for a total transaction of $549,075.00. Following the transaction, the executive vice president owned 28,935 shares of the company's stock, valued at $2,118,331.35. This trade represents a 20.58% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 163,377 shares of company stock valued at $11,082,485 over the last quarter. Insiders own 3.56% of the company's stock.
Institutional Investors Weigh In On Delek US
A number of hedge funds and other institutional investors have recently modified their holdings of DK. BlackRock Inc. purchased a new position in Delek US in the second quarter valued at $275,233,000. Arrowstreet Capital Limited Partnership lifted its holdings in Delek US by 26.7% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 1,596,093 shares of the oil and gas company's stock worth $71,936,000 after buying an additional 335,892 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in Delek US by 19.0% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,136,720 shares of the oil and gas company's stock worth $51,232,000 after buying an additional 181,820 shares during the last quarter. Bank of America Corp DE boosted its position in shares of Delek US by 118.0% during the 1st quarter. Bank of America Corp DE now owns 846,204 shares of the oil and gas company's stock worth $38,138,000 after acquiring an additional 458,004 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Delek US during the 2nd quarter worth about $22,987,000. 97.01% of the stock is currently owned by institutional investors and hedge funds.
Delek US Stock Performance
Shares of DK stock opened at $67.09 on Thursday. The company has a quick ratio of 0.92, a current ratio of 1.33 and a debt-to-equity ratio of 2.03. Delek US has a 52 week low of $25.85 and a 52 week high of $82.27. The stock has a market capitalization of $4.07 billion, a PE ratio of 3.56, a P/E/G ratio of 0.44 and a beta of 0.61. The firm has a 50 day moving average of $73.19 and a two-hundred day moving average of $54.30.
Delek US (NYSE:DK - Get Free Report) last posted its quarterly earnings results on Friday, November 6th. The oil and gas company reported $13.55 EPS for the quarter, topping the consensus estimate of $8.05 by $5.50. The business had revenue of $4.39 billion during the quarter, compared to the consensus estimate of $3.88 billion. Delek US had a net margin of 8.70% and a return on equity of 140.39%. The company's quarterly revenue was up 52.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $7.13 earnings per share. On average, research analysts predict that Delek US will post 19.53 EPS for the current fiscal year.
Delek US Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, November 18th. Investors of record on Tuesday, November 10th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.8%. This is a positive change from Delek US's previous quarterly dividend of $0.2550. The ex-dividend date of this dividend is Tuesday, November 10th. Delek US's dividend payout ratio is 6.37%.
About Delek US
(
Get Free Report)
Delek US Holdings, Inc. is an independent downstream energy company focused on petroleum refining and related logistics in the southern United States. Its refining operations are located in Texas, Arkansas and Louisiana, where it processes crude oil into transportation fuels and other petroleum products. Products from Delek US refineries include gasoline, diesel, jet fuel, asphalt and petroleum coke. The company also markets refined products to customers and operates midstream assets, including pipelines, terminals and storage facilities, through its subsidiary Delek Logistics Partners.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Delek US, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.
While Delek US currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.